Product Details

Mucorex-LS (60 ML)

Levosalbutamol Sulphate               1 mg

Ambroxol HCL                              30 mg

Guaiphenesin                                  50 mg

Each bottle contains 60 ml

  1. Sulphate is a selective beta-2 adrenergic agonist, Levosalbutamol acts as a bronchodilator, providing rapid relief by relaxing the smooth muscles of the airways. Ambroxol HCL, a mucolytic agent, plays a crucial role in breaking down and thinning mucus in the respiratory tract. By promoting the clearance of excessive mucus, Ambroxol facilitates easier expectoration, making it an invaluable addition to the syrup for individuals suffering from conditions like bronchitis and other respiratory infections.
  2. is an expectorant that works by loosening and thinning mucus in the airways, making it easier to clear through coughing.  We offer this product under the brand name Mucorex LS Syrup in 60 ml strength.

  • It helps alleviate bronchospasms, allowing for easier breathing.
  • It supports the breakdown of mucus, promoting its clearance from the respiratory tract.
  • It enhances the expectoration of mucus, facilitating its removal from the airways.

Levosalbutamol is a selective β2-adrenergic receptor agonist that acts on the smooth muscles of the respiratory tract. It promotes bronchodilation by stimulating β2 receptors, leading to relaxation of bronchial smooth muscles. Ambroxol is a mucolytic agent by breaking down the thick, sticky mucus, Ambroxol promotes easier expectoration and clearance of airways, providing relief from cough and congestion. Guaiphenesin is an expectorant that works by increasing the volume and reducing the viscosity of respiratory secretions.It helps in the loosening and thinning of mucus, making it easier to expel through coughing.

 Absorption:

This active ingredients are rapidly absorbed upon oral administration, ensuring a prompt onset of action.

Distribution:

The components of Mucorex-LS distribute themselves strategically in the respiratory system, optimizing their efficacy in addressing specific respiratory challenges.

Excretion:

Metabolism and excretion of the active ingredients occur primarily through renal and hepatic pathways, contributing to the elimination of the components from the body.

  • Mucorex LS syrup may not be suitable for children under 2 years old due to potential safety concerns.
  •  Patients with severe kidney dysfunction should use Mucorex LS with caution.
  •  Diabetic patients should monitor their blood glucose levels closely, as Levosalbutamol Sulphate may affect insulin sensitivity.

  • Caution is advised in individuals with cardiovascular disorders or other pre-existing conditions.
  • It should not be taken by pregnant or breastfeeding individuals.
  •  Avoid exceeding the recommended dosage, as an overdose may lead to adverse effects.
  • Maintain adequate fluid intake during Mucorex LS therapy to enhance its effectiveness in respiratory conditions.

The medical information on this website is provided as an information resource only. The information on this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider or a medical practitioner in understanding any information or in applying information that you might have come across, on this website. Please note that it dangerous to take any medication without doctor’s prescription or professional advice from a registered health practitioner. Do not use this information in place of a visit, consultation or advice of your healthcare providers.